Anthem Biosciences 20th AGM Approves Dividend, Director Appointments

Date: Wednesday, July 22, 2026
Time: Commenced at 3:30 p.m. IST and concluded at 4:40 p.m. IST
Location: Conducted entirely through Video Conferencing (VC) / Other Audio-Visual Means (OAVM)
Type of Meeting: 20th Annual General Meeting

The following ordinary and special businesses were transacted as per the notice convening the AGM:

Ordinary Businesses:

Resolution 1: Approval for adoption of the audited financial statements (including audited consolidated financial statements) of the company for the financial year ended March 31, 2026 and the reports of the Board of Directors and Auditors thereon (Ordinary Resolution)
Resolution 2: Approval for Declaration of dividend (Ordinary Resolution)
Resolution 3: Approval for the reappointment of Mr. K Ravindra Chandrappa (DIN: 01580534), who retires by rotation (Ordinary Resolution)

Special Businesses:

Resolution 5: Approval of the continuation of Mr. Ravikant Uppal (DIN: 00025970) as non-executive independent director upon attaining the age of 75 years (Special Resolution)
Resolution 6: Approval of commission payable to Independent Directors (Ordinary Resolution)
Resolution 7: Approval for increase in payment of remuneration to related parties holding an office or place of profit (Ordinary Resolution)
Resolution 8: Approval of the Upside Sharing Arrangement with Viridity Tone LLP (Ordinary Resolution)

The meeting was conducted through VC/OAVM in compliance with the Companies Act, 2013, SEBI LODR Regulations, and Secretarial Standard-2.
The facility for appointment of proxies was not available for this VC/OAVM meeting.
Authorized representatives of corporate members attended in accordance with the Companies Act, 2013.
Voting was conducted through remote e-voting prior to the meeting and through e-voting upon conclusion of the meeting.
The e-voting facility remained open for 15 minutes after the conclusion of the meeting for members who had not cast their votes earlier.

All resolutions set out in the notice were passed by the members with the requisite majority.
The specific voting results, total votes cast, percentage in favor/against, and participation breakdown by shareholder category were not provided in this proceedings document but were to be declared separately along with the Scrutinizer's Report.

Mr. Pramod S M, Designated Partner of M/s. BMP & Co. LLP, Practicing Company Secretaries, acted as the Scrutinizer for the voting process.
The Scrutinizer's Report along with voting results was to be declared within the prescribed timeline and uploaded on the websites of the Company and the Registrar and Transfer Agent, and submitted to the Stock Exchanges.

The meeting was convened in compliance with:

Divya Prasad, Company Secretary & Compliance Officer (Membership No: A41438) signed and submitted the proceedings to the stock exchanges.

The statutory registers and other documents referred to in the notice were made available electronically for inspection by members.
The reports of the Statutory Auditors (M/s. K.P. Rao & Co., Chartered Accountants) for FY 2025-26 did not contain any qualification, reservation or adverse remark.
Management presentations were made by Mr. Ajay Bhardwaj (Chairperson, MD & CEO) on company performance and strategic initiatives, and by Mr. Mohammed Gawir Baig (CFO) on operational and financial performance.
Members registered as speakers were provided opportunity to express views and seek clarifications.
The company's investor relations email address (investors.abl@anthembio.com) was provided for further queries.